Clinical Trials Directory

Trials / Completed

CompletedNCT06319859

Intrathecal Non-preservative-free Morphine With Bupivacaine Versus Intrathecal Bupivacaine Alone for Analgesia in Unilateral Inguinal Hernia Repair Surgeries

Intrathecal Non-preservative-free Morphine With Bupivacaine Versus Intrathecal Bupivacaine Alone for Analgesia in Unilateral Inguinal Hernia Repair Surgeries: A Randomized Controlled Clinical Trial.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the efficacy and safety of intrathecal non-preservative-free morphine and its effect on pain in patients undergoing unilateral inguinal hernia surgeries.

Conditions

Interventions

TypeNameDescription
DRUGMorphineThe patients will receive 0.1 mg morphine with 15 mg heavy bupivacaine intrathecally
DRUGPlaceboThe patients will receive 15 mg heavy bupivacaine with 0.1 ml saline intrathecally

Timeline

Start date
2024-08-03
Primary completion
2025-10-15
Completion
2025-11-25
First posted
2024-03-20
Last updated
2025-12-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06319859. Inclusion in this directory is not an endorsement.

Intrathecal Non-preservative-free Morphine With Bupivacaine Versus Intrathecal Bupivacaine Alone for Analgesia in Unilat (NCT06319859) · Clinical Trials Directory